Literature DB >> 33915094

Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss.

Siobhan Quenby1, Ioannis D Gallos2, Rima K Dhillon-Smith2, Marcelina Podesek2, Mary D Stephenson3, Joanne Fisher4, Jan J Brosens5, Jane Brewin6, Rosanna Ramhorst7, Emma S Lucas5, Rajiv C McCoy8, Robert Anderson9, Shahd Daher9, Lesley Regan10, Maya Al-Memar10, Tom Bourne10, David A MacIntyre10, Raj Rai10, Ole B Christiansen11, Mayumi Sugiura-Ogasawara12, Joshua Odendaal5, Adam J Devall2, Phillip R Bennett8, Stavros Petrou9, Arri Coomarasamy2.   

Abstract

Miscarriage is generally defined as the loss of a pregnancy before viability. An estimated 23 million miscarriages occur every year worldwide, translating to 44 pregnancy losses each minute. The pooled risk of miscarriage is 15·3% (95% CI 12·5-18·7%) of all recognised pregnancies. The population prevalence of women who have had one miscarriage is 10·8% (10·3-11·4%), two miscarriages is 1·9% (1·8-2·1%), and three or more miscarriages is 0·7% (0·5-0·8%). Risk factors for miscarriage include very young or older female age (younger than 20 years and older than 35 years), older male age (older than 40 years), very low or very high body-mass index, Black ethnicity, previous miscarriages, smoking, alcohol, stress, working night shifts, air pollution, and exposure to pesticides. The consequences of miscarriage are both physical, such as bleeding or infection, and psychological. Psychological consequences include increases in the risk of anxiety, depression, post-traumatic stress disorder, and suicide. Miscarriage, and especially recurrent miscarriage, is also a sentinel risk marker for obstetric complications, including preterm birth, fetal growth restriction, placental abruption, and stillbirth in future pregnancies, and a predictor of longer-term health problems, such as cardiovascular disease and venous thromboembolism. The costs of miscarriage affect individuals, health-care systems, and society. The short-term national economic cost of miscarriage is estimated to be £471 million per year in the UK. As recurrent miscarriage is a sentinel marker for various obstetric risks in future pregnancies, women should receive care in preconception and obstetric clinics specialising in patients at high risk. As psychological morbidity is common after pregnancy loss, effective screening instruments and treatment options for mental health consequences of miscarriage need to be available. We recommend that miscarriage data are gathered and reported to facilitate comparison of rates among countries, to accelerate research, and to improve patient care and policy development.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33915094     DOI: 10.1016/S0140-6736(21)00682-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  60 in total

Review 1.  Pregnancy in special populations: challenges and solutions practical aspects of managing von Willebrand disease in pregnancy.

Authors:  Ozlem Turan; Rezan Abdul Kadir
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

2.  Maternal non-steroidal anti-inflammatory drug exposure during pregnancy and risk of miscarriage: a systematic review and meta-analysis.

Authors:  Xian-Hua Ying; Dan-Ni Bao; Hai-Yin Jiang; Yu-Dan Shi
Journal:  Eur J Clin Pharmacol       Date:  2021-10-11       Impact factor: 2.953

3.  Communication after pregnancy and baby loss.

Authors:  G Crossingham; Paula Abramson
Journal:  BJA Educ       Date:  2022-04-19

4.  Maternal Thrombophilic and Hypofibrinolytic Genetic Variants in Idiopathic Recurrent Pregnancy Loss: a Continuing Mystery.

Authors:  Mahmoud Younis; Mohamed A M Ali; Doaa A Ghareeb; Rehab Youssef; Shadia A Fathy
Journal:  Reprod Sci       Date:  2022-08-15       Impact factor: 2.924

5.  Outsourcing Transcription: Extending Ethical Considerations in Qualitative Research.

Authors:  Marita Hennessy; Rebecca Dennehy; Jennifer Doherty; Keelin O'Donoghue
Journal:  Qual Health Res       Date:  2022-05-21

6.  Glucocorticoids Improve the Pregnancy Rate and Outcome in Women With Unexplained Positive Autoantibodies: A Systematic Review and Meta-Analysis.

Authors:  Ting Li; Yilin Yuan; Huixin Liu; Qun Lu; Rong Mu
Journal:  Front Med (Lausanne)       Date:  2022-05-11

Review 7.  Stem Cell-Based Trophoblast Models to Unravel the Genetic Causes of Human Miscarriages.

Authors:  Tatiana V Nikitina; Igor N Lebedev
Journal:  Cells       Date:  2022-06-14       Impact factor: 7.666

8.  Plasma level of mannose-binding lectin is associated with the risk of recurrent pregnancy loss but not pregnancy outcome after the diagnosis.

Authors:  C Nørgaard-Pedersen; L H Rom; R Steffensen; U S Kesmodel; O B Christiansen
Journal:  Hum Reprod Open       Date:  2022-06-07

9.  Value of Ethnicity or Race in More Accurate Prediction of Future Outcome in Couples with Recurrent Miscarriages.

Authors:  Marie-Louise van der Hoorn; Lisa Lashley
Journal:  Reprod Sci       Date:  2022-04-28       Impact factor: 2.924

10.  Protein-rich food intake and risk of spontaneous abortion: a prospective cohort study.

Authors:  Amelia K Wesselink; Sydney K Willis; Anne Sofie Dam Laursen; Ellen M Mikkelsen; Tanran R Wang; Ellen Trolle; Katherine L Tucker; Kenneth J Rothman; Lauren A Wise; Elizabeth E Hatch
Journal:  Eur J Nutr       Date:  2022-03-13       Impact factor: 4.865

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.